MA34314B1 - Préparation de paracétamol injectable stable, prête à l'emploi - Google Patents

Préparation de paracétamol injectable stable, prête à l'emploi

Info

Publication number
MA34314B1
MA34314B1 MA35461A MA35461A MA34314B1 MA 34314 B1 MA34314 B1 MA 34314B1 MA 35461 A MA35461 A MA 35461A MA 35461 A MA35461 A MA 35461A MA 34314 B1 MA34314 B1 MA 34314B1
Authority
MA
Morocco
Prior art keywords
paracetamol
ready
preparation
group
injectable stable
Prior art date
Application number
MA35461A
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Uni Pharma Kleon Tsetis Pharmaceutical Lab S A
Ioulia Tseti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Lab S A, Ioulia Tseti filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Lab S A
Publication of MA34314B1 publication Critical patent/MA34314B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention concerne une solution aqueuse de paracétamol administrable par perfusion intraveineuse qui comprend pour le paracétamol en solution au moins un composé de stabilisation-dissolution pris dans le groupe composé de cyclodextrines, au moins un composé stabilisateur portant au moins un groupe fonctionnel thiol et au moins un composé stabilisateur pris dans le groupe composé de sels de thiamine.
MA35461A 2010-05-19 2011-05-18 Préparation de paracétamol injectable stable, prête à l'emploi MA34314B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10005258A EP2389923B1 (fr) 2010-05-19 2010-05-19 Formule de paracétamol injectable, stable et prête à utiliser
PCT/EP2011/002482 WO2011144335A1 (fr) 2010-05-19 2011-05-18 Préparation de paracétamol injectable stable, prête à l'emploi

Publications (1)

Publication Number Publication Date
MA34314B1 true MA34314B1 (fr) 2013-06-01

Family

ID=42338244

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35461A MA34314B1 (fr) 2010-05-19 2011-05-18 Préparation de paracétamol injectable stable, prête à l'emploi

Country Status (22)

Country Link
US (1) US8877817B2 (fr)
EP (1) EP2389923B1 (fr)
CN (1) CN102985069B (fr)
AP (1) AP3151A (fr)
BR (1) BR112012029212A2 (fr)
CA (1) CA2799666C (fr)
CY (1) CY1113999T1 (fr)
DK (1) DK2389923T3 (fr)
ES (1) ES2403121T3 (fr)
HK (1) HK1182315A1 (fr)
HR (1) HRP20130184T1 (fr)
MA (1) MA34314B1 (fr)
MY (1) MY160458A (fr)
PL (1) PL2389923T3 (fr)
PT (1) PT2389923E (fr)
RU (1) RU2519764C1 (fr)
SI (1) SI2389923T1 (fr)
SM (1) SMT201300038B (fr)
TN (1) TN2012000516A1 (fr)
UA (1) UA104381C2 (fr)
WO (1) WO2011144335A1 (fr)
ZA (1) ZA201208605B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
WO2016008546A1 (fr) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Formulation aqueuse comprenant du paracétamol et de l'ibuprofène
CN105797166A (zh) * 2016-03-30 2016-07-27 吉林长白山药业集团股份有限公司 用羟丙基环糊精包合对乙酰氨基酚制成液体制剂的方法
WO2018192664A1 (fr) 2017-04-20 2018-10-25 Hyloris Developments Sa Procédé de préparation d'une composition à faible teneur en oxygène dissous, comprenant de l'acétaminophène, et éventuellement un ou plusieurs ains, et une composition obtenue à partir de celui-ci
WO2019180072A1 (fr) 2018-03-22 2019-09-26 Bayer Pharma Aktiengesellschaft Composition pharmaceutique parentérale consistant en du bialanate de néladénoson
US20230165928A1 (en) * 2020-04-30 2023-06-01 Blue Sky Innovation, Llc Compositions and methods comprising stable reduced glutathione
GR1010637B (el) * 2023-01-13 2024-02-15 Ιουλια Κλεωνος Τσετη Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH648371A5 (de) 1982-01-29 1985-03-15 Fischer Ag Georg Anschlusseinrichtung fuer armaturen.
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US20040045546A1 (en) * 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
WO2009064928A1 (fr) * 2007-11-13 2009-05-22 Cadence Pharmaceuticals Acétaminophène par voie intraveineuse en dose réduite
US20110015273A1 (en) * 2008-01-17 2011-01-20 Rajnarayana Kandhagatla Stable pharmaceutical aqueous compositions
US20090246276A1 (en) * 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
CA2714721C (fr) * 2008-02-29 2016-02-23 Meiji Dairies Corporation Agent antiallergique

Also Published As

Publication number Publication date
PL2389923T3 (pl) 2013-06-28
EP2389923B1 (fr) 2013-01-30
MY160458A (en) 2017-03-15
TN2012000516A1 (en) 2014-04-01
UA104381C2 (uk) 2014-01-27
ZA201208605B (en) 2013-09-25
CA2799666C (fr) 2016-02-16
CY1113999T1 (el) 2016-07-27
SI2389923T1 (sl) 2013-06-28
CN102985069A (zh) 2013-03-20
WO2011144335A8 (fr) 2012-12-06
DK2389923T3 (da) 2013-03-18
US20130210922A1 (en) 2013-08-15
CA2799666A1 (fr) 2011-11-24
PT2389923E (pt) 2013-03-28
HRP20130184T1 (hr) 2013-05-31
RU2519764C1 (ru) 2014-06-20
EP2389923A1 (fr) 2011-11-30
US8877817B2 (en) 2014-11-04
BR112012029212A2 (pt) 2020-09-29
HK1182315A1 (en) 2013-11-29
WO2011144335A1 (fr) 2011-11-24
AP2012006597A0 (en) 2012-12-31
ES2403121T3 (es) 2013-05-14
CN102985069B (zh) 2014-11-26
SMT201300038B (it) 2013-07-09
AP3151A (en) 2015-03-31

Similar Documents

Publication Publication Date Title
MA34314B1 (fr) Préparation de paracétamol injectable stable, prête à l'emploi
MA42678B1 (fr) Nouveaux analogues nucléosidiques substitués à cycle aromatique bicyclique 6-6 pour une utilisation en tant qu'inhibiteurs de prmt5
BR112014019667A2 (pt) formulação de anticorpo abeta
MA38143A1 (fr) Composition comprenant des agents de lutte biologique
MA37477A1 (fr) Modulateurs des voies du complément et leurs utilisations
EA200970047A1 (ru) Водные суспензии тмс278
BR112015026644A2 (pt) composto de tetrazolinona e uso do mesmo
EA200970510A1 (ru) Гетеромоноциклическое соединение и его применение
CO6362001A2 (es) Compuestos de 4-isoprpilfenilglucitol
MA34361B1 (fr) Dérivés de tétrahydro-pyrido-pyrimidine
MA35941B1 (fr) Préparation pharmaceutique contenant un dérivé de dihydrochinazoline à action antivirale
MA38661A1 (fr) Composés hétéro-aromatiques et leur utilisation en tant que ligands d1 de la dopamine
CL2013002794A1 (es) Compuestos derivados de espiro(indazol-5,4’-piperidin) sustituidos, inhibidores de acetil-coa carboxilasa y su composicion farmaceutica, util para tratar una enfermedad, afeccion o trastorno modulado por la inhibicion de acetil-coa carboxilasa tal como diabetes, enfermedad de higado graso no alcoholico (hgna) o resistencia hepatica a insulina.
MA35032B1 (fr) Derives de glycoside et leurs utilisations dans le traitement du diabete
BR112013016770A2 (pt) formulação farmacêutica, fármaco biofarmacêutico, seringa ou caneta pré-preenchida, uso de uma formulação farmacêutica
BR112013022213A2 (pt) administração parenteral de tapentadol
MA39146A1 (fr) Combinaisons de gabapentanoïdes et de ligands des récepteurs sigma
BR112013017520A2 (pt) composto bicíclico ou sal do mesmo
ATE364402T1 (de) Stabile injizierbare diclofenac- zubereitungen
MA38679A1 (fr) Modulateurs du récepteur de cxcr7
EA201401231A1 (ru) Фармацевтические комбинации, предназначенные для лечения метаболических нарушений
MA38410B1 (fr) Composés d'azétidinyloxyphénylpyrrolidine
AR062217A1 (es) Derivados de 4- trimetilamonio-3- aminobutirato y 4- trimetilfosfonio-3-aminobutirato como inhibidores de la cpt
MA34910B1 (fr) Dérivés de 2-methoxy-pyridin-4-yl
BR112016009214A8 (pt) uso de um composto para preparação de um medicamento para o tratamento de distrofia muscular e composição farmacêutica